Please login to the form below
Santen
This page shows the latest Santen news and features for those working in and with pharma, biotech and healthcare.
The best work in healthcare communications shines at virtual Communiqué Awards
Sponsored by ENGINE MHP. Winner: The World Through Patients’ Eyes: Immersive Role Play Training for Ophthalmologists by Mearns &Pike for Santen.
Latest news
-
Mearns & Pike, Electric Putty and Evoke KYNE make a clean sweep at Communiqué 2020
Santen. “To have won four awards in one night feels truly amazing.
-
Havas Lynx Group and VCCP Health win big at PM Society Awards
Other pharma Gold winners included ALK, Heart UK, Immunocore, Janssen, Mundipharma, Novo Nordisk and Santen. ... Innovation: HealthCircle for Santen. Mixed Media: VCCP Health for Edwards Lifesciences.
-
AbbVie's 'The Story of HS' wins at PMEA 2016
off competition from Novartis, Santen UK and Tillotts Pharma UK.
-
NICE no for new eye disease drug
NICE's preliminary recommendation has been to ask Santen Pharmaceutical for more information on Ikervis (ciclosporin) for treating severe keratitis in adults with dry eye disease which has not improved despite
-
Antibiotics among 7 new drugs backed by EMA
The final two drugs to feature in the list of positive opinions were Santen's Ikervis (ciclosporin) for the treatment of the eye condition severe keratitis and MDCO's Raplixa (human
More from news
Approximately 1 fully matching, plus 11 partially matching documents found.
Latest Intelligence
-
The good, the bad and the ugly
Ophthalmology. Ophthalmology is dominated by a small number of the same therapies marketed by different companies in different regions; Regeneron, Bayer and Santen all market Eylea, whereas Novartis and Roche market
-
Deal Watch table for May 2014
653. Merck &Co / Santen. Asset / product acquisition. 2. Ophthalmology products in Japan, Europe and Asia Pacific with sales of $400m.
-
Pharma deals during May 2014
Not content with the Bayer deals, Merck &Co also divested its ophthalmic business (mainly Timolol) in Japan, Asia Pacific and Europe to its licensee Santen.
-
Deal Watch table for March 2014
22. Tracon Pharmaceuticals/ Santen Pharmaceutical Co. Licence. Tracon's anti‐endoglin antibodies, including TRC105 for wet AMD (p2).
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
Luis Iglesias heads Santen EMEA
His promotion sees him succeed Shigeo Taniuchi. Luis Iglesias has been promoted as Santen’s EMEA head, a move that sees him succeed Shigeo Taniuchi - who returns to Japan to become ... Iglesias initially joined Santen in 2017 as its senior vice
-
Paolo Casati named as general manager of Santen Italy
Has over 30 years of experience in the sector. Eye care specialist Santen Pharma has appointed Paolo Casati as general manager of its Italian subsidiary. ... I am very excited to join the team to establish Santen Italy as one of the major companies of
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Medical Editor
-
Competitive
- PHE study finds people who have had COVID-19 can still transmit the virus
- Sinovac’s COVID-19 vaccine appears safe in older adults
- PHE study finds people who have had COVID-19 can still transmit the virus
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- New study identifies drugs that are safe to use in COVID-19 treatment
- AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
- Onyx Health Celebrates Its 10th Anniversary with Five New Hires
- Merck’s appeal to restore hepatitis C patent verdict against Gilead fails
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Trial combining British and Russian COVID-19 vaccines could begin in February
- New Oxford research institute established to tackle antimicrobial resistance
- EU proposes vaccine-sharing mechanism with low-income countries
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- Recent years have seen a significant shift in drug development to specialty areas...
- 2020 - a year to remember or forget?
- 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
- The search for effective drug treatments for COVID-19
- PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
Quick links
Infographics
